154 related articles for article (PubMed ID: 27245195)
1. DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) study.
Callahan CL; Wang Y; Marian C; Weng DY; Eng KH; Tao MH; Ambrosone CB; Nie J; Trevisan M; Smiraglia D; Edge SB; Shields PG; Freudenheim JL
Epigenetics; 2016 Sep; 11(9):643-652. PubMed ID: 27245195
[TBL] [Abstract][Full Text] [Related]
2. Active and secondhand smoke exposure throughout life and DNA methylation in breast tumors.
Callahan CL; Bonner MR; Nie J; Wang Y; Tao MH; Shields PG; Marian C; Eng KH; Trevisan M; Freudenheim JL
Cancer Causes Control; 2019 Jan; 30(1):53-62. PubMed ID: 30617699
[TBL] [Abstract][Full Text] [Related]
3. Lifetime exposure to ambient air pollution and methylation of tumor suppressor genes in breast tumors.
Callahan CL; Bonner MR; Nie J; Han D; Wang Y; Tao MH; Shields PG; Marian C; Eng KH; Trevisan M; Beyea J; Freudenheim JL
Environ Res; 2018 Feb; 161():418-424. PubMed ID: 29197760
[TBL] [Abstract][Full Text] [Related]
4. Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients.
Pirouzpanah S; Taleban FA; Mehdipour P; Atri M
J Mol Med (Berl); 2015 Aug; 93(8):917-34. PubMed ID: 25805039
[TBL] [Abstract][Full Text] [Related]
5. Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer.
Spitzwieser M; Holzweber E; Pfeiler G; Hacker S; Cichna-Markl M
Breast Cancer Res; 2015 Sep; 17(1):125. PubMed ID: 26370119
[TBL] [Abstract][Full Text] [Related]
6. The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review.
Su Y; Wang X; Li J; Xu J; Xu L
Drug Des Devel Ther; 2015; 9():5439-45. PubMed ID: 26491255
[TBL] [Abstract][Full Text] [Related]
7. Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer.
Yadav P; Masroor M; Nandi K; Kaza RCM; Jain SK; Khurana N; Saxena A
Asian Pac J Cancer Prev; 2018 Feb; 19(2):443-448. PubMed ID: 29480000
[TBL] [Abstract][Full Text] [Related]
8. Methylation Profiles of BRCA1, RASSF1A and GSTP1 in Vietnamese Women with Breast Cancer.
Vu TL; Nguyen TT; Doan VTH; Vo LTT
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1887-1893. PubMed ID: 30049201
[TBL] [Abstract][Full Text] [Related]
9. Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review.
de Ruijter TC; van der Heide F; Smits KM; Aarts MJ; van Engeland M; Heijnen VCG
Breast Cancer Res; 2020 Jan; 22(1):13. PubMed ID: 32005275
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients.
Sharma G; Mirza S; Yang YH; Parshad R; Hazrah P; Datta Gupta S; Ralhan R
Cell Oncol; 2009; 31(6):487-500. PubMed ID: 19940364
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
[TBL] [Abstract][Full Text] [Related]
12. DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study.
Tao MH; Shields PG; Nie J; Millen A; Ambrosone CB; Edge SB; Krishnan SS; Marian C; Xie B; Winston J; Vito D; Trevisan M; Freudenheim JL
Breast Cancer Res Treat; 2009 Apr; 114(3):559-68. PubMed ID: 18463976
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation status of the FHIT gene and Fhit expression: association with HER2/neu status in breast cancer patients.
Jeong YJ; Jeong HY; Lee SM; Bong JG; Park SH; Oh HK
Oncol Rep; 2013 Nov; 30(5):2270-8. PubMed ID: 23969757
[TBL] [Abstract][Full Text] [Related]
14. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease.
Singal R; Ferdinand L; Reis IM; Schlesselman JJ
Oncol Rep; 2004 Sep; 12(3):631-7. PubMed ID: 15289848
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of aberrant methylation of RARbeta2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer.
Tomizawa Y; Iijima H; Nomoto T; Iwasaki Y; Otani Y; Tsuchiya S; Saito R; Dobashi K; Nakajima T; Mori M
Lung Cancer; 2004 Dec; 46(3):305-12. PubMed ID: 15541815
[TBL] [Abstract][Full Text] [Related]
16. Analysis of FHIT gene methylation in egyptian breast cancer women: association with clinicopathological features.
Zaki SM; Abdel-Azeez HA; El Nagar MR; Metwally KA; S Ahmed MM
Asian Pac J Cancer Prev; 2015; 16(3):1235-9. PubMed ID: 25735361
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma.
Fackler MJ; McVeigh M; Evron E; Garrett E; Mehrotra J; Polyak K; Sukumar S; Argani P
Int J Cancer; 2003 Dec; 107(6):970-5. PubMed ID: 14601057
[TBL] [Abstract][Full Text] [Related]
18. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
Rosenbaum E; Hoque MO; Cohen Y; Zahurak M; Eisenberger MA; Epstein JI; Partin AW; Sidransky D
Clin Cancer Res; 2005 Dec; 11(23):8321-5. PubMed ID: 16322291
[TBL] [Abstract][Full Text] [Related]
20. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
